The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...

Australian agri-biotech company Nbryo has completed a $10m capital raising to accelerate genetic improvement in the global ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Taysha Gene Therapies Inc. (NASDAQ:TSHA) is a clinical-stage biotechnology company that develops and commercializes ...

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

In a breakthrough study, scientists have transferred a courtship behavior from one species to another, triggering the recipient to perform this completely foreign act as if it was its own. While genes ...

Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single ...

A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...

Gene editing is a technology used to treat and prevent various diseases ... Real sells Vinícius to fund Haaland transfer to Real in Korea-linked chain With persistent transfer rumors of Vinícius ...

A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...

Biomarin Pharmaceutical Inc. (($BMRN)) announced an update on their ongoing clinical study. BioMarin Pharmaceutical Inc. is conducting a long-term ...